Viewing Study NCT03258593


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT03258593
Status: COMPLETED
Last Update Posted: 2025-12-19
First Post: 2017-08-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Sponsor: National Cancer Institute (NCI)
Organization: